GlassScriptPhysician profile
Jennifer Brookes
NPI 1336667898
$4,649.49
in general payments reported to CMS, 2019-2025
10 companies · $3,883 in 2025
The $3,883 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $189 · 2023: $262 · 2024: $315 · 2025: $3,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,405 · Food and Beverage: $1,236 · Travel and Lodging: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,405.00 |
| Food and Beverage | $1,235.70 |
| Travel and Lodging | $819.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Autolus INC | $3,487.19 | 2025 | |
| Sanofi-Aventis U.S. LLC | $250.00 | 2023-2024 | |
| Incyte Corporation | $244.40 | 2023-2025 | Niktimvo, Jakafi |
| Celgene Corporation | $190.23 | 2024 | Reblozyl, Onureg |
| Syndax Pharmaceuticals, INC. | $112.73 | 2025 | Revuforj |
| Jazz Pharmaceuticals INC. | $97.76 | 2022 | |
| Glaxosmithkline, LLC. | $91.29 | 2022 | |
| Janssen Biotech, INC. | $81.69 | 2025 | Carvykti |
| Legend Biotech USA INC. | $73.53 | 2025 | Carvykti |
| Pfizer INC. | $20.67 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Brookes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.